Russia rolls out first approved COVID-19 drug

iStock [illustration]

As number of COVID-19 cases in Russia crossed 500,000, the government has rolled out a drug to treat the novel coronavirus even though clinical trials are still underway.

The country's health ministry has approved the use of the anti-viral drug, registered under the name Avifavir, under a special accelerated process.

In a press release, the state financial backer said the drug has been delivered to some hospitals and clinics in the country.

The country's RDIF sovereign wealth fund has a 50 per cent share in a joint venture with the drug's manufacturer ChemRar.

There is currently no vaccine for COVID-19, with human trials of several existing antiviral drugs yet to show efficacy.

So far, the country has 502,436 positive cases and the death toll stands at 6,532.

More from International

Coming Up on Dubai Eye

  • Extra Time

    7:00pm - 8:00pm

    Chris & Robbie bring you the latest from the sporting world plus interviews with upcoming and legendary sporting stars.

  • The Night Shift with Mark Lloyd

    8:00pm - 10:00pm

    Musicians and music, entertainers and entertainment, industry gossip and songs selected by you, get ready to bring your night time to life!

On Dubai Eye

  • Dubai Eye 103.8: On The Frontline

    Dubai Eye 103.8's Georgia Tolley speaks to the Emirate's top doctors and health officials to find out why the UAE is winning the fight against COVID-19.

  • Mark's Summer Bucket List

    Mark Lloyd has been giving you ideas to keep you busy this summer, from staycations to online improv workshops!

Business Breakfast